In two separate studies, researchers demonstrate how synthetic biology can be used to tackle a difficult issue in cancer immunotherapy: the way immunotherapy-related approaches focused on short-term killing of tumor cells may fail to eradicate tumors because growth of tumors happens on longer timescales.
Here, two research groups present strategies to allow better control over the timing of immunotherapy using synthetic gene circuits whereby anti-tumor cell functions can be activated on demand, or only when CAR T cells are in direct contact with tumor cells.
Among the arsenal of cancer immunotherapy treatments, chimeric antigen receptor (CAR) T therapies involve ex vivo engineering of a patient’s cancer-killing T cells to express CARs that recognize specific molecules on a tumor’s surface. These are then injected back into patients to elicit an immune response against cancer cells. However, CAR T cell therapies are typically optimized for short-term cellular responses (e.g., killing of tumor cells) and may not achieve long-term systemic tumor eradication.
To allow precise control of CAR T cell function over time, the researchers leveraged recently developed synthetic Notch receptors to design enhanced CAR T cells with a second receptor. The second receptor can recognize a tumor antigen and subsequently cause the T cell to release cytokine interleukin-2, but only when the CAR T cells are in direct contact with tumor cells.
In a mouse model, the approach allowed CAR T infiltration into solid pancreatic and melanoma tumors, resulting in substantial tumor eradication. Critically, say the authors, these tumor-targeted IL-2 delivery circuits offer a potential way to target tumors locally while minimizing longstanding toxicity issues with IL-2.
In their study, another group developed a toolkit of 11 programmable synthetic transcription factors that could be activated on demand with the timed administration of FDA-approved small molecule inducers. Using these tools, the authors engineered human immune cells that activate specific cellular programs – such as proliferation and antitumor activity – on demand. This enables stepwise and time-controlled therapeutic responses.
“The combination of the two technological advances presented by the 2 gorups will allow for an unprecedented ability to precisely control the state of therapeutic cell populations not only at the time of injection,” write the authors in their perspective, “but also while the immune response is unfolding within the patient.”
https://www.science.org/doi/10.1126/science.ade0156
https://www.science.org/doi/10.1126/science.aba1624
Synthetic gene circuits enhance cancer immunotherapies
- 732 views
- Added
Latest News
Alzheimer's disease symptom…
By newseditor
Posted 27 Jun
Gene-regulatory networks in…
By newseditor
Posted 27 Jun
How apoE influences Aβ aggr…
By newseditor
Posted 26 Jun
How do plants break down da…
By newseditor
Posted 26 Jun
A new tool for neurological…
By newseditor
Posted 26 Jun
Other Top Stories
Exposure to chemical mixtures during pregnancy alters brain develop…
Read more
Making human brain stem cells grow for longer periods
Read more
A single transcription factor reprograms astrocytes in mouse striatum
Read more
Converting human stem cells to 8-cell totipotent embryo-like cells
Read more
AI and high content screening uncover hidden signatures of Parkinso…
Read more
Protocols
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
Publications
Immunometabolism in atheros…
By newseditor
Posted 27 Jun
Long-range inhibitory neuro…
By newseditor
Posted 27 Jun
The microtubule-dynamin bin…
By newseditor
Posted 27 Jun
High sugar diet-induced fat…
By newseditor
Posted 27 Jun
Brain repair mechanisms aft…
By newseditor
Posted 27 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar